In 1759 analysed patients with symptomatic rheumatic heart disease in India, digoxin vs placebo reduced death or new/worsening heart failure (31.4% vs 35.5%; HR 0.82) over median 2.1 years; all-cause death did not differ. Suspected toxicity stopped 10 vs 1.
RCTn = 1,769
Karthikeyan et al. Digoxin in Patients With Symptomatic Rheumatic Heart Disease: A Randomized Clinical Trial